Aligos Therapeutics, Inc.
USD5.25
-0.10 (-1.87%)
CEO
Lawrence Blatt
IPO Date
2020-10-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.34
Prev. Close
$5.35
Day Low
$5.01
Day High
$5.55
52W Low
$5.01
52W High
$13.69
Market Cap
$0.03B
Volume
0.17M
| 37,485 |
| $7.03 |
| 11 Mar 2026 | BLATT LAWRENCE | director, officer: President and CEO | A-Award | Acquired | 105,840 | $7.03 |
| 19 Feb 2026 | Aneja Nikhil | Principal Accounting Officer | Disposed | 3,800 | $16.00 |
| 19 Feb 2026 | Aneja Nikhil | Principal Accounting Officer | Disposed | 2,640 | $11.74 |
| 19 Feb 2026 | Aneja Nikhil | Principal Accounting Officer | Disposed | 7,155 | $16.87 |
| 19 Feb 2026 | Aneja Nikhil | Principal Accounting Officer | Disposed | 3,600 | $8.68 |
| 18 Jul 2025 | BLATT LAWRENCE | director, officer: President and CEO | A-Award | Acquired | 179,800 | $8.68 |
| 18 Jul 2025 | Symons Julian A. | See Remarks | A-Award | Acquired | 16,000 | $8.68 |
| 18 Jul 2025 | Calhoun Lesley Ann | See Remarks | A-Award | Acquired | 40,185 | $8.68 |